Project is dead
Hi Sharkzz1, Cameron1Love, lunnatic, FIEX and all other posters and interested parties.
Firstly, our apologies for not returning to this thread sooner.
Just to clarify, the ClinTex CTi project is not dead nor failed far from it.
Last year, after extensive consultation with stakeholders in the pharma industry and regulators (FDA and EMA), we agreed a set of further developments to our CTi platform to address some immediate needs in terms of functionality for regulatory compliance. It was decided that doing this in advance of a fund-raise via token sale would ensure a smooth transition of the CTi platform into live clinical trial environments, thus improving early uptake and on-boarding of clients without delay post-TGE.
Also discussed by the management team was the current market environment (this was Jan 2018), and how best to generate and protect value for token holders post TGE.
In conclusion a decision was taken to delay our token generation event to allow time for the aforementioned CTi platform developments to be completed, and concurrently to allow market conditions to stabilise, thus protecting our token purchasers value by launching the CLX token into a more stable environment.
We believe that this decision was the most responsible outcome, in respect of our would-be token purchasers.
The good news is that our development is almost complete, and we hope to launch the token sale early next year on a prominent cryptocurrency exchange.
We will keep updating as developments continue, through our media channels.
Thank you for your patience,
The ClinTex Team
